|mankind share price in india||0.02||0.3||6927||24|
|mankind pharma india share price||0.69||0.4||7238||67|
|mankind pharma share price today india||1.49||0.1||7936||34|
|share price of mankind pharma||1.51||0.6||2588||77|
|mankind pharma share price today||1.19||0.2||2948||61|
|mankind share price nse||1.97||0.3||2138||22|
|mankind pharma share price history||1.26||0.8||7594||34|
|mankind pharma share price today live||0.61||0.8||8758||9|
|mankind pharma limited share price||0.49||0.3||6491||19|
|mankind pharma ltd share price||1.06||0.4||3127||90|
|mankind pharma share price nse||1.73||0.8||7096||68|
|mankind share price bse||1.86||0.9||5046||82|
|mannkind corporation share price||1.1||0.6||4307||12|
|mankind pharma share price bse||1.18||0.5||6274||48|
|hinduja mankind pharma share price||0.32||0.9||214||13|
|mankind pharma stock price||1.02||0.4||3987||93|
|mannkind stock price today||1.1||0.8||5602||13|
|price of mannkind stock||0.68||0.6||4209||23|
|mannkind stock price news||0.59||0.1||9552||42|
|mannkind corporation stock price||0.21||0.5||92||53|
|mannkind corp stock price||1.84||0.3||6962||29|
|mannkind stock quote today||1.11||0.5||8977||84|
|mannkind corporation stock analysis||0.22||1||4548||50|
Today, Mankind is one of the top 5 leading pharmaceutical companies in India with a dedicated field force of over 1968 professionals. Mankind Pharma achieved a turnover of Rs. 17250 million for the fiscal year 2019-20 with a growth of 20%. Mankind Pharma contributed 30% in Mankind Group of Company’s sales which was Rs. 56760 million in 2019-20 .What is BDR Pharma's partnership with Mankind Pharma?
Under the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary license from Eli Lilly and Company. Mankind Pharma will be distributing the same, it added.What is Mankind Pharma's new family support policy?
With the launch of this new policy, the company intends to support the families of its employees amid the second wave of the coronavirus pandemic, Mankind Pharma said in a statement. The company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma said in a statement.Will Mankind Pharma be sold to Mauritius-based private equity investors?
Competition Commission has given its green signal to the proposed 11 percent stake sale in Mankind Pharma to two Mauritius-based private equity investors. The Delhi-based firm, which manufactures various over-the-counter products including condoms, said the new facility would produce bulk APIs.